Aibion Technologies is a technology company.
Aibion Technologies has raised $50K across 1 funding round.
Aibion Technologies has raised $50K in total across 1 funding round.
Aibion Technologies is a MedTech company specializing in AI-driven medical data analysis and software engineering, primarily focused on healthcare innovations such as digital pathology and molecular genetic research. They develop advanced software solutions that enhance the accuracy and diagnostic value of medical data and images, serving healthcare providers, researchers, and medical institutions. Their products and services aim to improve patient care, optimize therapy, and reduce healthcare costs by leveraging AI to support oncology diagnosis and other medical fields. Additionally, Aibion supports early-stage MedTech startups through an accelerator program offering mentorship, resources, and funding to foster innovation in healthcare technology[1][3].
Founded around 2020, Aibion Technologies emerged from a team passionate about combining medical expertise with AI and software engineering to address challenges in oncology diagnosis and digital pathology. The company started with a focused product strategy in digital pathology and gradually expanded into laboratory information management systems (LIMS) and molecular genetics software. A key milestone was the establishment of a joint laboratory with the Belarusian State Medical University (BSMU) in 2020, leading to the development of HistoCloud, a digital histology platform tested in Belarusian medical institutions. This collaboration also produced a COVID-register tool and fostered educational initiatives integrating medicine and IT[1][3].
Aibion rides the growing trend of AI integration in healthcare, particularly in medical imaging and diagnostics. The timing is critical as healthcare systems worldwide seek to improve diagnostic accuracy, reduce costs, and accelerate research through digital transformation. Market forces such as increasing demand for precision medicine, regulatory support for AI in healthcare, and the rise of digital pathology create favorable conditions for Aibion’s solutions. By bridging medical expertise and AI, Aibion influences the broader ecosystem by advancing medical data management, supporting research, and nurturing innovation through its accelerator program[1][3].
Looking ahead, Aibion Technologies is poised to expand its impact by scaling its AI-powered platforms like HistoCloud and deepening collaborations with medical institutions and educational bodies. Trends such as personalized medicine, AI-driven diagnostics, and integrated healthcare IT systems will shape their growth trajectory. Their continued support for MedTech startups could further position them as a key enabler in the healthcare innovation ecosystem. As AI adoption in medicine accelerates, Aibion’s blend of domain expertise and technology innovation will likely enhance their influence and market presence in the coming years[1][3].
Aibion Technologies has raised $50K in total across 1 funding round.
Aibion Technologies's investors include Expert Dojo.
Aibion Technologies has raised $50K across 1 funding round. Most recently, it raised $50K Seed in September 2020.
| Date | Round | Lead Investors | Other Investors |
|---|---|---|---|
| Sep 1, 2020 | $50K Seed | Expert Dojo |